Expert offers strategies for survival in today's CR environment

June 2008
Clinical Trials Administrator;Jun2008, Vol. 6 Issue 6, p70
The article offers suggestions to clinical trial (CT) investigators and professionals on handling the challenges in the clinical research industry. Investing in training program, as suggested, will likely helped familiarized the staff with the CT site's standard operating procedures. A careful review of the research protocol is said to be the first step to negotiating the budget issue with a sponsor. The importance of having a cross indemnification agreement in a contract between the CT investigators and the pharmaceutical company is also advised.


Related Articles

  • Using Public and Private Data for Clinical Operations. Sears, Claire // Applied Clinical Trials;Dec2016/Jan2017, Vol. 25 Issue 12, p22 

    The article focuses on use of public and private data for clinical research. Topics discussed include investing in study for delivering time and budget predictions by pharmaceutical companies, need to provide accurate representation of mid-point data, using clinical trial management system for...

  • Top Three Misconceptions of Adaptive Trials. Eisebitt, Reinhard; Voilmar, Joachim; Borkowski, Michael // Applied Clinical Trials;May2008, Vol. 17 Issue 5, p62 

    The article discusses the top three misconceptions of adaptive trials. It states that adaptive or flexible design is a new statistical methodology, tool or formula of biostatisticians. New technology designs change the clinical research process. It indicates that a prerequisite in the successful...

  • The Ultimate Risk Factor. Snyder, Steve // Contract Pharma;Sep2011, Vol. 13 Issue 7, p38 

    The article offers the author's insights on the utilization of contract research organizations (CROs)to conduct preclinical studies of drugs in the U.S. He explores issues which may occur at some CROs such as unanticipated toxicology findings, operational failures, and regulatory issues. He...

  • Effects of empowerment on pharmacists' organizational behaviors. Kahaleh, Abir; Gaither, Caroline A.; Kahaleh, Abir Abby // Journal of the American Pharmacists Association: JAPhA;Nov/Dec2005, Vol. 45 Issue 6, p700 

    Objective: To investigate the effects of power factors, need for achievement, and empowerment on commitment, loyalty, identification, and job turnover intention among pharmacists.Design: Cross-sectional study.Setting: United States.Participants:...

  • Financial Steps for Sites. Warnock, Neil; Lester, Matthew // Applied Clinical Trials;2010 Partnerships Supplement, p20 

    The article explains that the key to clinical trial management is dependent to the management of financial data. It notes that successful financial results demand sites to select studies that maximize strategic and financial goals and effectively manage budgets, collection and patient accrual....

  • Jury's Still Out on How Best to Handle Trial Data. Ward, Philip // Applied Clinical Trials;Dec2013/Jan2014, Vol. 22 Issue 12, p10 

    The article discusses that the European Medicines Agency has been reviewing the comments received by the agency from June 2013-September 2013 related to its draft policy on clinical trial data. It states that the agency has received comments during a public consultation on the policy from a wide...

  • Clinical Supply Issues Challenge Sponsors and Patients. Wechsler, Iill // Applied Clinical Trials;Dec2013/Jan2014, Vol. 22 Issue 12, p10 

    The article discusses a survey conducted by the International Society for Pharmaceutical Engineers related to the experiences of patients with clinical trial supplies which examines the influence of packaging and labeling of supplies on the success of a clinical study. Topics discussed include...

  • Discovery Outsourcing Report. Aldrich, Steven // Contract Pharma;Sep2012, Vol. 14 Issue 7, p120 

    The article reports on the involvement in outsourcing by pharmaceutical companies in the BRIC countries. It highlights the services that are being outsourced including clinical trial management, manufacturing, and drug discovery. It highlights the process of drug discovery including target...

  • Quintiles Launches China CRO, Kun Tuo.  // Biomedical Market Newsletter;12/14/2011, Vol. 21, p1 

    The article informs that the company Quintiles has announced the launch of Kun Tuo, a local contract research organization (CRO) in order to service the unique needs of the Chinese biopharmaceutical industry and multinational biopharma companies operating in China. It mentions that Kun Tuo will...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics